[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-356310-105":3,"detail-sidebar-cat-0-en-105":85,"doc-detail-356310-en":135},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":78,"head_meta":80,"extra_data":82,"updated_unix":84},105,"en","evaluation-of-quantitative-polymerase-chain-reaction-for-detecting-brca1-or-brca2-copy-number-loss-in-high-grade-serous-ovarian-cancer","Evaluation of quantitative polymerase chain reaction for detecting BRCA1 or BRCA2 copy number loss in high-grade serous ovarian cancer","","Accurate identification of BRCA1/2 copy number loss (CNL) is clinically relevant in high grade serous tubo-ovarian carcinoma (HGSOC), yet CNL detection remains underdeveloped. This study evaluated quantitative PCR (qPCR) for BRCA1/2 CNL detection in two patient cohorts (n=355 and n=86) and a cell line panel (n=10), using sequencing-based copy number assessment as comparator. qPCR showed poor sensitivity (BRCA1: 0–11.5%, BRCA2: 10–36.8%) and frequent BRCA1/2 co-loss not reproduced by sequencing. Reference gene RPPH1 CN differed by co-loss status, but agreement with sequencing and an additional TERT assay was still poor.",{"@graph":14,"@context":77},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/evaluation-of-quantitative-polymerase-chain-reaction-for-detecting-brca1-or-brca2-copy-number-loss-in-high-grade-serous-ovarian-cancer/356310/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/evaluation-of-quantitative-polymerase-chain-reaction-for-detecting-brca1-or-brca2-copy-number-loss-in-high-grade-serous-ovarian-cancer/356310.png","ImageObject",300,407,{"name":42,"@type":43},"Emma Wilson","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-07","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69,73],{"name":60,"@type":61,"acceptedAnswer":62},"What was the goal of this study?","Question",{"text":63,"@type":64},"To assess quantitative PCR (qPCR) as a method for detecting BRCA1/2 copy number loss in high grade serous ovarian cancer, compared with sequencing-based copy number assessment.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How effective was qPCR at detecting BRCA1/2 copy number loss?",{"text":68,"@type":64},"qPCR sensitivity was poor in both clinical cohorts: BRCA1 ranged from 0–11.5% and BRCA2 from 10–36.8%.",{"name":70,"@type":61,"acceptedAnswer":71},"Did qPCR identify BRCA1/2 co-loss in a way that matched sequencing data?",{"text":72,"@type":64},"No. BRCA1 and BRCA2 co-loss was frequently detected by qPCR but was not mirrored in matched sequencing results.",{"name":74,"@type":61,"acceptedAnswer":75},"What overall conclusion does the study reach about using qPCR for CNL detection?",{"text":76,"@type":64},"qPCR did not effectively detect BRCA1/2 CNL in HGSOC, potentially due to CN variation at reference assay sites, so caution is needed when using qPCR for CNL in genomically unstable cancers.","https://schema.org",{"og:url":32,"og:type":79,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":81,"canonical":32},"index,follow",{"doc_id":83,"site_id":7},356310,1791073705,{"code":4,"msg":86,"data":87},"success",[88,92,96,100,105,110,115,119,124,127,131],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Exam",70,"exam",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},5,"Comic",60,"comic",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},6,"Technology",50,"technology",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":113,"slug":114},7,"Healthcare",40,"healthcare",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":117,"slug":118},8,30,"research-report",{"id":120,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":122,"slug":123},9,"Religion & Spirituality",20,"religion-spirituality",{"id":122,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":122,"slug":126},"World Cup","world-cup",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":128,"slug":130},10,"Lifestyle","lifestyle",{"id":132,"doc_module":4,"doc_module_name":25,"category_name":133,"show_sort_weight":101,"slug":134},19,"General","general",{"code":4,"msg":86,"data":136},{"doc_id":83,"user_id":137,"nickname":42,"user_avatar":138,"doc_module":4,"category_id":116,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":139,"file_id":140,"file_url":141,"file_type":142,"file_size":143,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":144,"language":145,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":146,"faqs":147,"seo_title":148,"seo_description":12,"update_tm":149,"read_time":150,"preview_page_count":33,"preview_urls":151},3848291630094,"https://eur-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nEvaluation of quantitative polymerase chain reaction for detecting BRCA1 or BRCA2 copy number loss in high-grade serous ovarian cancer  \nA. J. Oswald1􀀍, R. L. Hollis1, M. Churchman1, I. Croy1, A. Ewing2, J. P. Thomson1,  \nL. J. Stillie1,3, E. Merry1, M. Albertella4, J. V. Forment4, P. Roxburgh5, C. A. Semple2,  \nC. S. Herrington1 & C. Gourley1  \nCopy number loss (CNL) of tumour suppressors genes, such as BRCA1/2, are frequent but underresearched tumour driver events. Accurate identification of BRCA1/2 CNL has potential therapeutic implications, particularly in high grade serous tubo-ovarian carcinoma (HGSOC), and cost-effective detection methods are desirable. This study assessed quantitative PCR (qPCR) as a method of BRCA1/2 CNL detection in HGSOC, in two patient cohorts (cohort 1 n = 355, cohort 2 n = 86) and a cell line panel (n = 10) using sequencing-based copy number (CN) assessment as a comparator (panelbased sequencing in cohort 1; whole genome sequencing [WGS] in cohort 2 and the cell line panel) . The qPCR sensitivity for detecting BRCA1/2 CNL in both clinical cohorts was poor (BRCA1; 0-11.5%, BRCA2; 10-36.8%). There was frequent co-occurrence of BRCA1 and BRCA2 CNL by qPCR (cohort 1;  \nOR 71.8), which was not mirrored in matched sequencing data. There was a significantly higher CN value for the reference gene RPPH1 in cases with qPCR-identified BRCA1/2 co-loss (cohort 1; RPPH1 median CN 5.2 ± 4.8 versus 2.5 ± 1.3, p \u003C 0.0001) . In a cell line panel, there was poor agreement between BRCA1/2 CN measured by qPCR versus WGS, and an additional reference assay (TERT) did not improve agreement. Overall, qPCR did not effectively detect BRCA1/2 CNL in HGSOC, which may be due toCN variation at the reference assay sites. This work underscores the need for caution when utilising qPCR for detecting CNL events, particularly in genomically unstable cancers.  \nKeywords Copy number loss, Quantitative polymerase chain reaction, High grade serous ovarian cancer, BRCA1/2  \nStructural variants (SVs) represent a diverse class of genomic events that may amplify, delete or rearrange genomic regions.1 Among SVs, large scale genomic gains and losses that generate copy number variation are common, and typically involve oncogene amplification or loss of tumour suppressor genes.2 Despite being less well characterised compared to short pathogenic variants (mutations), these alterations are recognised to playa critical role in tumourigenesis by affecting gene dosage and regulatory mechanisms3,4, with recent studies suggesting at least 30% of cancer genomes harbour pathogenic SVs.1,5.  \nAccurately identifying copy number variants in tumours has significant clinical implications, as these events can be potentially leveraged therapeutically.1 For example, SVs such as NTRK fusions and HER2 copy number amplification have been successfully therapeutically targeted across multiple cancer types.6,7 Furthermore, copy number variants serve as valuable prognostic or predictive biomarkers; for example, CCNE1 copy number gain is associated with chemoresistance in high grade serous tubo-ovarian carcinoma (HGSOC) .8,9 Despite the  \n1The Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK. 2MRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK. 3Cancer Research UK Beatson Institute, Institute of Cancer Sciences, University of Glasgow, G61 1BD Glasgow, UK. 4Bioscience, Oncology R&D, AstraZeneca, Cambridge, UK.  \n5School of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, UK. 􀀍 email: [ailsa.oswald@ed.ac.uk](ailsa.oswald@ed.ac.uk)  \n[www. nature.com/scientificreports/](www. nature.com/scientificreports/)  \ngrowing understanding of oncogenic copy number gain events, research on copy number loss events i","cbCaipUwvXx2JsE6","https://ap.wps.com/l/cbCaipUwvXx2JsE6","pdf",2479572,13,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion","[{\"question\":\"What was the goal of this study?\",\"answer\":\"To assess quantitative PCR (qPCR) as a method for detecting BRCA1/2 copy number loss in high grade serous ovarian cancer, compared with sequencing-based copy number assessment.\"},{\"question\":\"How effective was qPCR at detecting BRCA1/2 copy number loss?\",\"answer\":\"qPCR sensitivity was poor in both clinical cohorts: BRCA1 ranged from 0–11.5% and BRCA2 from 10–36.8%.\"},{\"question\":\"Did qPCR identify BRCA1/2 co-loss in a way that matched sequencing data?\",\"answer\":\"No. BRCA1 and BRCA2 co-loss was frequently detected by qPCR but was not mirrored in matched sequencing results.\"},{\"question\":\"What overall conclusion does the study reach about using qPCR for CNL detection?\",\"answer\":\"qPCR did not effectively detect BRCA1/2 CNL in HGSOC, potentially due to CN variation at reference assay sites, so caution is needed when using qPCR for CNL in genomically unstable cancers.\"}]","Evaluation of quantitative polymerase chain reaction for detecting BRCA1 or BRCA2 copy number loss in high-grade serous ovarian cancer | PDF",1790124584,33,[152,156,160,164],{"page_no":22,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/80b93167ca7327b013fa3680d2bc2fa4.webp",983,1291,{"page_no":26,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b71e3c2dc3b51f853eb35d2e91a36cee.webp",982,1290,{"page_no":30,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b9926083cb579a80638ab3cdf77a8516.webp",981,1289,{"page_no":33,"url":165,"width":166,"height":167},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/426ce58341c004faf590f3b4e267a77f.webp",980,1287]